|
[1]Andrea Z, Franco T, Paolo C, et al.Cardiac electrophysiological ab-normalities in patients with cirrhosis[J].Journal of Hepatology, 2006, 44∶994-1002.
|
|
[2]Henriksen JH, Fuglsang S, Bendsten F, et al.Dyssynchronous elec-trical and mechanical systole in patients with cirrhosis[J].J Hepatol, 2002, 36∶513-520.
|
|
[3]Loveen P, Vinay C, Paul J, et al.Prolonged QTc interval and its re-lationship to autonomic cardiovascular reflexes in patients with cirrho-sis[J].Journal of Hepatology, 2001, 35∶733-738.
|
|
[4]Dillon JF, Plevris JN, Nolan J, et al.Autonomic function in cirrho-sis as-sessed by cardiovascular reflex test and 24-hour heart ratevariability[J].Am J Gastroenterol, 1994, 89∶1544-1547.
|
|
[5]Henriksen JH, Bendtsen F, Hansen EF, et al.Acute non-selectiveβ-adrenergic blockade reduces prolonged frequency-adjusted Q-Tinterval interval in patients with cirrhosis[J].J Hepatol, 2004, 40∶423-239.
|
|
[6]Henriksen JH, Gotze JP, Fuglsang S, et al.Increased circulatingpro-brain natriuretic peptide (proBNP) and brain natriuretic pep-tide (BNP) in patients with cirrhosis:relation to cardiovascular dys-function and severity of disease[J].Gut, 2003, 52∶1511-1517.
|
|
[7]肖文斌, 刘玉兰, 肝硬化性心肌病[J].中华肝脏病杂志, 2002, 10∶154-155.
|
|
[8]Trevisani F, Merli M, Savelli F, et al.QTinterval in patients withnoncirrhotic portal hypertension and in cirrhotic patients treated withtransjugular intrahepatic portosystemic shunt[J].J Hepatol, 2003, 38∶461-467.
|
|
[9]Garcia GM, Hernandez MA, Lopez SA, et al.Reversal of QTinter-val electrocardiographic alterations in cirrhotic patients undergoingliver transplantation[J].Transplant P roc, 1999, 31 (6) ∶2366-2367.
|
|
[10]Liu HQ, Ma Z, Lee SS, et al, Contribution of nitric oxide to thepathogenesis of cirrhotic cardiomyopathy in bile duct-ligatedrats[J].Gastroenternology, 2000, 118∶937-944.
|
|
[11]Tran Duc AT, Schwab AJ, Simard A, et al.Reduction in hepaticendothelin-1 clearance in cirrhosis[J].Clin Sci, 2003, 105∶227-234.
|
|
[12]Duru F, Barton M, Luscher TF, et al.Endothelin and cardiac ar-rhythmias:do endothelin antagonists have a therapeutic potential asantiarrhythmic drugs?[J].Cardiovasc Res, 2001, 49∶272-280.
|
|
[13]Mohacsi A, Magyar J, Tamas B, et al.Effects of endothelins oncardiac and vascular cells:new therapeutic target for the future?[J].Curr Vasc Pharmacol, 2004, 2∶53-63.
|
|
[14]Jaue DN, Ma Z, Lee ss.Cardiac muscarinic receptor function inrats with cirrhotic cardiomyopathy[J].Hepatology, 1997, 25∶1361-1365.
|
|
[15]徐克成, 肝功能试验的评价[J].中华消化杂志, 2004, 24 (1) ∶1-31.
|
|
[16]Myers RP, Lee SS.Cirrhotic cardiomyopathy and liver transp lanta-tion[J].Liver Transp 1, 2000, 6 (4 Supp11) ∶s44-s52.
|
|
[17]Tan HL, Hou CJ, Lauer MR, et al.Electrophysiologic mechanismsof the long QTinterval syndromes and torsade depointes[J].Ann In-tern Med, 1995, 122∶701-714.
|
PDF下载 ( 170 KB)
本文二维码
下载:
